Table 1 Overview of the approved NBCA-R set
Section | Variables |
|---|---|
Identification | Â |
| Â | Sex |
| Â | Date of birth |
General | |
| Â | RT institute |
| Â | Date planning CT scan |
| Â | Laterality tumour |
Total treatment time | |
| Â | Date first fraction RT |
| Â | Date last fraction RT |
| Â | Date of the first RT consultation of this radiation plan |
Target areas | |
| Â | Whole breast: yes/no |
| Â | Partial breast: yes/no |
| Â | Chest wall: yes/no |
| Â | Boost breast or chest wall: yes/no |
| Â | Interpectoral lymph nodes: yes/no |
| Â | Axillary lymph node levels I-II: yes/no |
| Â | Axillary lymph node levels III-IV: yes/no |
| Â | Internal mammary lymph nodes: yes/no |
| Â | Boost lymph nodes: yes/no |
Prescribed dose | |
 Elective dose (local/regional) | Number of fractions |
 Elective dose (local/regional) | Dose per fraction (Gy)a |
 Dose on PTV boost tumour bed | Number of fractions |
 Dose on PTV boost tumour bed | Dose per fraction (Gy) |
 Dose on PTV boost lymph nodes | Number of fractions |
 Dose on PTV boost lymph nodes | Dose per fraction (Gy) |
 Type of boost | Simultaneous integrated boost vs sequential boost |
Doses distribution on target areas | |
 PTV-electiveb | D2% (Gy) |
 PTV-electiveb | D98% (Gy) |
 PTV-electiveb | Dmean (Gy) |
 PTV-Boost-tumour bed | V95% of prescribed dose (%) |
 PTV-Boost-tumour bed | D2% (Gy) |
 PTV-Boost-tumour bed | D98% (Gy) |
 PTV-Boost-tumour bed | Dmean (Gy) |
 PTV-Boost- axillary lymph nodes | V95% of prescribed dose (%) |
 PTV-Boost- axillary lymph nodes | D2% (Gy) |
 PTV-Boost- axillary lymph nodes | D98% (Gy) |
 PTV-Boost- axillary lymph nodes | Dmean (Gy) |
 PTV-elective minus PTV boostc | D2% (Gy) |
 PTV-elective minus PTV boostc | D98% (Gy) |
 PTV-elective minus PTV boostc | Dmean (Gy) |
Dose in normal tissues | |
 Heart | D2% (Gy) |
 Heart | Dmean (Gy) |
 Ipsilateral breast | V95% of the prescribed boost dose in the body (mL) |
| Â | Volume of CTV breast (mL) |
 Lungs | Mean dose (Gy), both lungs |